First Time Loading...

Kamada Ltd
NASDAQ:KMDA

Watchlist Manager
Kamada Ltd Logo
Kamada Ltd
NASDAQ:KMDA
Watchlist
Price: 5.37 USD 2.87% Market Closed
Updated: May 2, 2024

Kamada Ltd
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Kamada Ltd
Net Income (Common) Peer Comparison

Comparables:
CLGN
B
BLRX
URGN
ENTX
B
BONS

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
Kamada Ltd
NASDAQ:KMDA
Net Income (Common)
$8.3m
CAGR 3-Years
-21%
CAGR 5-Years
-18%
CAGR 10-Years
34%
Collplant Biotechnologies Ltd
NASDAQ:CLGN
Net Income (Common)
-$7m
CAGR 3-Years
-7%
CAGR 5-Years
-2%
CAGR 10-Years
N/A
B
BioLine RX Ltd
TASE:BLRX
Net Income (Common)
-$60.6m
CAGR 3-Years
-26%
CAGR 5-Years
-21%
CAGR 10-Years
-14%
Urogen Pharma Ltd
NASDAQ:URGN
Net Income (Common)
-$102.2m
CAGR 3-Years
7%
CAGR 5-Years
-6%
CAGR 10-Years
N/A
Entera Bio Ltd
NASDAQ:ENTX
Net Income (Common)
-$8.9m
CAGR 3-Years
7%
CAGR 5-Years
3%
CAGR 10-Years
N/A
B
Bonus Biogroup Ltd
TASE:BONS
Net Income (Common)
-₪31m
CAGR 3-Years
-17%
CAGR 5-Years
-13%
CAGR 10-Years
-12%

See Also

What is Kamada Ltd's Net Income (Common)?
Net Income (Common)
8.3m USD

Based on the financial report for Dec 31, 2023, Kamada Ltd's Net Income (Common) amounts to 8.3m USD.

What is Kamada Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
34%

The average annual Net Income (Common) growth rates for Kamada Ltd have been -21% over the past three years , -18% over the past five years , and 34% over the past ten years .